SPAC Daily: Chamath’s DNAC Adjourns With no Vote

by David Drapkin | Jul 6, 2022 | SPACs

DNAC is the latest in a string of SPACs that appears to be having more trouble than expected in getting across the finish line. Podcast: Know Who Drives ReturnDaily SPAC NewsletterFull SPAC ListingJune 2022 SPAC Market Review Chamath Palihapitiya’s Social...

HSAQ Strikes $158M Deal with Orchestra BioMed

by David Drapkin | Jul 5, 2022 | SPACs

Health Sciences Acquisitions Corporation 2 (HSAQ) kicks off the week with a SPAC Deal Podcast: Know Who Drives ReturnDaily SPAC NewsletterFull SPAC Listing Health Sciences Acquisitions Corporation 2 (HSAQ) struck a deal with Orchestra BioMed to take the company public...

Weekly Executive & Director Moves (July 1)

by David Drapkin | Jul 1, 2022 | CEO / CFO / Director Resignations & Appointments, Featured

Boardroom Alpha provides in-depth analytics and tracking of all public company executives and officers. Below is a rundown of people moves made at notable companies this past week. Get a demo today to see how you can receive real-time alerts and in-depth analytics....

SPAC Market Review – June 2022

by David Drapkin | Jul 1, 2022 | Featured, SPAC Monthly Review, SPACs

SPAC market sentiment remains low as maturity wall looms SPAC land in June predominantly saw a continuation of the market activity we have witnessed over the last few months. Namely, a decline in deals, IPOs, participants, prices (pre- and post-deSPAC) while there was...

SPAC Daily: MSPR Discloses Shares for PLTR and CANO

by David Drapkin | Jun 29, 2022 | SPACs

Plus the rest of the day’s news in SPACs Podcast: Know Who Drives ReturnDaily SPAC NewsletterFull SPAC Listing Everyone’s favorite DeSPAC, MSP Recovery (MSPR), whose shares closed at $2.50 today after just over a month of DeSPAC, disclosed additional...